Alzheimer’s disease (AD) is a complex progressive neurodegenerative disease characterized by the accumulation of Aβ plaques and tau NFTs, which are considered to result in neuronal loss and cognitive decline. This slide deck discusses neurobiology and aetiology for AD and highlights topics as risk factors, pathopsysiological hypotheses, and the development and importance of biomarkers.

This slide deck has been developed by Joseph Therriault, PhD, McGill University, Montréal, Québec, Canada; and Professor Serge Gauthier, McGill University, Montréal, Québec, Canada, in collaboration with Cambridge Medical – A Prime Global agency.

Index for
slide deck

Introduction

Neurobiology and aetiology
Neurobiology and aetiology
file_download Download slide in HQ
Alzheimer’s disease research timeline
Alzheimer’s disease research timeline

Diagnosis of AD has developed from a pathological approach to a more clinical and exclusionary approach.1,3 NIA-AA Criteria published in 2011, combined with a clinical and biological approach developed by the International Working Group (IWG), allowed for the emergence of…

file_download Download slide in HQ
Alzheimer’s disease is not synonymous with dementia
Alzheimer’s disease is not synonymous with dementia

References on slide:
1.Alzheimer’s Disease International website. Dementia facts and figures. Available at: https://www.alzint.org/about/dementia-facts-figures/. Accessed 1 June 2023.

2.Alzheimer’s Association website. What is dementia? Available at: https://www.alz.org/al…

file_download Download slide in HQ
What is neurodegeneration?
What is neurodegeneration?

Aβ and tau pathology in AD results in neuroinflammation, mitochondrial dysfunction, metabolic dysregulation, and protein deficiency.1 The resulting neurotoxicity and disturbed neuroplasticity that occur lead to neurodegeneration.1 In vivo, neurodegeneration in AD is ident…

file_download Download slide in HQ

Risk factors

Risk factors
Risk factors
file_download Download slide in HQ
What factors are at play in Alzheimer’s disease?
What factors are at play in Alzheimer’s disease?

While the most prominent risk factor for AD is increasing age, the disease develops as a result of several risk factors that converge.2 Environmental factors such as traumatic brain injury, ischemia, hypoxia, neurotoxins, infections, lifestyle, metabolic parameters, and c…

file_download Download slide in HQ
Genetic risk factors
Genetic risk factors

The estimated heritability of AD is approximately 70%, and does not differ between sex.1,9 To date, 75 risk loci have been identified for AD and related dementias.8 Several studies in multiple ethnic groups have associated the APOE gene with familial-AD and sporadic late-…

file_download Download slide in HQ
Modifiable lifestyle factors and prevention strategies
Modifiable lifestyle factors and prevention strategies

AD has a long prodromal phase, during which early prevention is important to slow progression of the disease.1 Psychosocial factors such as educational attainment and bilingualism work to enhance cognitive activity, processing, and intellectual capacities.1,3 Regular soci…

file_download Download slide in HQ
Accumulation of dementia risk factors over time
Accumulation of dementia risk factors over time

Maintaining good physical health in individuals with dementia is important for cognition.1 In early life (i.e., <45 years), lack of education has been associated with an increased risk of dementia.1 In middle life (i.e., 45–65 years), and not necessarily in later life (i.…

file_download Download slide in HQ

Related content

image Image The pathology of ischaemic stroke is complex, but commonly involves the formation of a clot that travels in the blood to or within the brain and becomes lodged in the blood vessels of the brain (a thromboembolism), which can reduce or block blood flow (an occlusion).
Pathology of Ischaemic Stroke

The pathology of ischaemic stroke is complex, but commonly involves the formation of a clot that travels in the blood to or within the brain and becomes lodged in the blood vessels of the brain (a thromboembolism), which can reduce or block blood flow (an occlusion).

22.04.2024 Neurobehavioral Consequences of Stroke
image Image Post-stroke neuropsychiatric symptoms (NPS) - Fatigue
Post-stroke Neuropsychiatric Symptoms (NPS) – Fatigue

Post-stroke fatigue is an under-recognized NPS, which healthcare professionals should anticipate in patients.

22.04.2024 Neurobehavioral Consequences of Stroke
image Image Brain circuitry and emotional lability
Brain Circuitry and Emotional Lability

Emotional lability describes episodes of involuntary and uncontrollable crying and/or laughing, outside of socially appropriate circumstances and when it is incongruent with the patient’s emotional state.

22.04.2024 Neurobehavioral Consequences of Stroke